West Pharmaceutical Services, Inc.

WSTNYSEHealthcare● Active

$321.53

+$7.03(+2.24%)

Market Cap$22.7B

P/E Ratio—

52W High$330.88

52W Low$206.8

Avg Volume882K

Open$317.43

Beta1.18

Net Income Financials Revenue

West Pharmaceutical Services, Inc. (WST) Net Income & Profit History

Annual & trailing net income, net margin, YoY change, and peer profitability context.

WST · net income · updated Jun 8, 2026

Core profitability metrics

WST · net income · margin · TTM · CAGR

Net income was $493.7M for FY2025 (fiscal year ending 2025-12-31), up 0.2% year-over-year. Net profit margin was 16.1%. Based on available data, West Pharmaceutical Services, Inc. has been profitable since at least 2011.

FY2025 Net Income$493.7M▲ +0.2% YoY

Trailing 12M (TTM)$542.7Mtrailing 4 quarters sum

Net Profit Margin16.1%$493.7M ÷ $3.07B

YoY Change+0.2%—

5-Year CAGR+7.4%FY2020 → FY2025

FormulaNet Margin = Net Income ÷ Revenue × 100TTM = trailing 4 quarters sumCAGR → N/A if either endpoint ≤ 0

Source: FMP /income-statement · US GAAP · USDUpdated: Jun 8, 2026

Annual net income history

Net Income (bars) · Net Profit Margin % (line)

Net IncomeNet LossNet Margin %★ First Profit: 2011

▸ FMP /income-statement · Annual · WST net income history · WST profit margin

Annual net income data

WST · net income history · annual / quarterly

Fiscal YearNet IncomeYoY ChangeNet MarginRevenue

FY2025$493.7M▲ +0.2%16.1%$3.07B

FY2024$492.7M▼ 17.0%17.0%$2.89B

FY2023$593.4M▲ +1.3%20.1%$2.95B

FY2022$585.9M▼ 11.5%20.3%$2.89B

FY2021$661.8M▲ +91.2%23.4%$2.83B

Net income vs peers (Healthcare)

WST vs peers · net income

#CompanyNet IncomeYoYNet MarginRelative

West Pharmaceutical Services, Inc.YOU

WST

$493.7M+0.2%16.1%

Eli Lilly and Company

LLY

$20.64B+94.9%31.7%

77%

UnitedHealth Group Incorporated

Healthcare · Sorted by Net Income · FMP /income-statementFull Net Income Rankings →

About Net Income & Methodology

West Pharmaceutical Services, Inc. (WST) reported net income of $493.7M for FY2025 (fiscal year ending 2025-12-31), up 0.2% year-over-year. The net profit margin was 16.1% — meaning the company kept $0.16 of every dollar of revenue as profit.

Based on available data, West Pharmaceutical Services, Inc. has been profitable since at least 2011. Net income reached a peak of $661.8M in FY2021. Data available for 15 fiscal years.

West Pharmaceutical Services, Inc.'s net profit margin was 16.1% for FY2025, based on the latest annual results.

Investors sometimes search for "West Pharmaceutical Services, Inc. net worth" — the company's market capitalization is a separate figure from WST net income. Data sourced from FMP /income-statement · US GAAP · USD.

Figures tie to SEC 10-K/10-Q and FMP /income-statement where noted.

Revenue Financial statements Earnings Forecast Price history Market cap Free cash flow

Frequently asked questions

WST net income · 5 questions

West Pharmaceutical Services, Inc. is profitable. The company reported net income of $493.7M for FY2025, a net profit margin of 16.1%. Net income was up 0.2% year-over-year. Based on available data, West Pharmaceutical Services, Inc. has been profitable since at least 2011.

is WST profitabledoes WST make a profitWST profitabilityWST profitable company

▸ Source: FMP /income-statement · GAAP · West Pharmaceutical Services, Inc. · West Pharmaceutical Services, Inc. SEC 10-K & 10-Q filings · US GAAP · Last updated: Jun 8, 2026